Magrilan

Magrilan

fluoxetine

Manufacturer:

Medochemie

Distributor:

Medochemie
Full Prescribing Info
Contents
Fluoxetine hydrochloride.
Description
Each capsule contains 20 mg Fluoxetine as the Hydrochloride.
Action
MAGRILAN is a new antidepressant with a different molecule to all existing antidepressants.
In animal studies Fluoxetine showed to exert directly on nonadrenergic and dopaminergic receptors.
The exerted activity is probably due to the selective inhibition of the serotonin intake in the presynaptic neurons.
Indications/Uses
Depression of various origin.
Depression with anxiety symptoms.
Dosage/Direction for Use
MAGRILAN is administered orally once or twice daily. The dosage is 20-60 mg daily.
In older patients dosage should not exceed 60 mg/day.
Contraindications
Hypersensitivity to Fluoxetine.
Special Precautions
Sexual dysfunction: Selective serotonin reuptake inhibitors (SSRIs)/serotonin norepinephrine reuptake inhibitors (SNRIs) may cause symptoms of sexual dysfunction. There have been reports of long-lasting sexual dysfunction where the symptoms have continued despite discontinuation of SSRIs/SNRIs.
It is not advisable to prescribe Fluoxetine to people driving vehicles or machinery.
In renal impaired patients accumulation of the drug may occur.
Dosage should be adjusted accordingly.
Use with caution in severe hepatic impairment.
Use in Pregnancy & Lactation: Animal studies did not reveal any teratogenicity for Fluoxetine. However it is not advisable to administer to pregnant women or lactating mothers.
Use In Pregnancy & Lactation
Animal studies did not reveal any teratogenicity for Fluoxetine. However it is not advisable to administer to pregnant women or lactating mothers.
Side Effects
MAGRILAN is generally well tolerated. Anticholinergic effects (constipation, dryness of the mouth etc) as well as CNS symptoms like nausea, vertigo, somnolence, headache may occur.
Loss of appetite has been registered to occur frequently.
Sedation, weakness and myalgia have also been reported to occur but they are extremely rare.
Rash (Discontinue treatment. May be associated with vasculitis, anaphylaxis and pulmonary inflammation or fibrosis).
MIMS Class
Antidepressants
ATC Classification
N06AB03 - fluoxetine ; Belongs to the class of selective serotonin reuptake inhibitors. Used in the management of depression.
Presentation/Packing
Form
Magrilan cap 20 mg
Packing/Price
10 × 10's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in